Newsfeeds Archive - Page 2 of 9

1 minute read

Why Is Healthcare Services Provider Cardinal Health Stock Trading Lower Today?

February 1, 12:52 PM

Cardinal Health reports strong Q2 FY24 results: Adjusted EPS up 38% to $1.82, beating consensus. Q2 revenue for pharmaceutical segment rises 12% to $53.5 billion. Raised FY24 EPS guidance to $7.20-$7.35.

CAH

4 minute read

Nasdaq Futures Rebound As Traders Eye Apple, Meta, Amazon Earnings: Analyst Flags ‘January Barometer’ That Bodes Well For The Year

By Shanthi Rexaline

February 1, 8:27 AM

After ending January with modest gains, the major averages now look to earnings catalysts to drive momentum, with futures higher in first trading session of February.

AAPL

8 minute read

Earnings

Earnings Scheduled For February 1, 2024

By Benzinga Insights

February 1, 6:03 AM

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on revenue of $75.66 billion.

AAPL

1 minute read

Earnings

Earnings Preview: Cardinal Health

By Benzinga Insights

January 31, 10:01 AM

Cardinal Health (NYSE:CAH) is set to give its latest quarterly earnings report on Thursday, 2024-02-01. Here’s what investors…

CAH

3 minute read

Tech Titans Microsoft, Apple Lead ‘Magnificent Seven’ Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?

By Shanthi Rexaline

January 29, 6:51 AM

An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.

AAPL

1 minute read

What’s Going On With Cardinal Health Shares Today?

By Lekha Gupta

January 9, 11:26 AM

Cardinal Health Inc (NYSE: CAH) shares are trading lower by around 4% after the company provided an update on its FY24 outlook and ongoing portfolio review.

CAH

1 minute read

Cardinal Health Updated FY24 Adj EPS Guidance to High End of $6.75-$7.00 Vs $6.95 Est, Sees Execution of a New $250M Accelerated Share Repurchase Program in Q2, Reiterated its Long-Term Targets Reflecting 12%-14% Growth of Adj EPS

By Benzinga Newsdesk

January 9, 7:52 AM

Fiscal 24 outlook update The company updated fiscal year 2024 non-GAAP diluted EPS guidance to the high end of its $6.75 to $7.00 range. This update is driven by anticipated

CAH

2 minute read